A carregar...
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment
A 44-year-old male developed interstitial lung disease (ILD) during treatment with rituximab (375 mg/m(2) weekly intravenous × 4 weeks) for the management of immune thrombocytopenia (ITP). After 1 month of treatment he developed dyspnea, fever (38.9 °C), an increase of C-reactive protein (CRP) and w...
Na minha lista:
| Publicado no: | Drug Saf Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5005575/ https://ncbi.nlm.nih.gov/pubmed/27747720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40800-015-0010-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|